Opioid Analgesics

These are general guidelines.  Patient care requires individualization based on patient needs and responses.  Lower doses should be used initially, then titrated up to achieve pain relief.

 

Drug

Route

Starting Dose

(Adults > 50 Kg)

Onset

Peak

Duration

Metabolism

Half Life

Comments

Codeine

PO

IM

SQ

30 - 60 mg q 4 hr

15 - 30 mg q 4 hr

15 - 30 mg q 4 hr

30 min

15 - 30 min

30 - 60 min

  hr

30 - 60 min

2 - 4 hr

6 hr

4 - 6 hr

4 - 8 hr

Liver

2 - 4 hr

· IV use (even at low doses and when given very slowly) may cause marked decrease in blood pressure; IV use is not recommended.

· IM or SQ routes are the preferred parenteral routes.

Fentanyl

(Sublimaze®)

 

 

(Duragesic®)

 

 

IM

IV

 

 

Trans-dermal

 

5 mcg/Kg q 1 - 2 hr

0.25 - 1 mcg/Kg as needed

 

25 mcg/hr

 

 

7 - 8 min

Immediate

 

 

12 - 24 hr

20 - 50 min

1 - 5 min

 

 

24 hr

1 - 2 hr

30 - 60 min

48 - 72 hr

Liver

1 - 6 hr*

· Transdermal should NOT be used to treat acute pain.

· Transdermal patch should be used only in opioid tolerant patients.  Effects of patch last for 18 - 24 hours after the patch is removed.

· Use of IV fentanyl is restricted to Oncology, Burn Service, Palliative Care, Intensive Care Units or based on recommendation by the Pain Service.  Appropriate monitoring is required. Refer to Nursing Policies 8.021 and 8.025.

Hydrocodone with acetaminophen**

(Lortab®, Vicodin®)

PO

5 - 10 mg hydrocodone      q 4 - 6 hr

60 min

2 hr

4 - 6 hr

Liver

4 hr

Available at UIHC as:

· Tablet with 5 mg hydrocodone and 500 mg acetaminophen.

· Elixir with 2.5 mg hydrocodone and 167 mg acetaminophen

   per 5 ml.

Hydromorphone

(Dilaudid®)

 

 

PO

IM/SQ

Slow IV

 

2 - 4 mg q 4 - 6 hr

2 mg q 4 - 6 hr

0.2 - 0.6 mg q 2 - 3 hr

 

30 min

15 - 20 min

15 - 20 min

 

60 min

60 min

60 min

 

4 - 5 hr

4 - 5 hr

4 - 5 hr

 

Liver

 2 - 3 hr

 

 

· Chronic treatment may require q 3 - 4 hour dosing.

· IV doses should be administered over at least 2-3 minutes.

 

Meperidine

(Demerol®)

IM/SQ

IV

50 - 150 mg q 3-4 hr

25 - 50 mg q 1-2 hr

10 - 45 min

2 - 5 min

30 - 60 min

20 min

2 hr

2 hr

Liver

2 - 3 hr

· More than 72 hr of continuous use can cause accumulation of

   normeperidine which can lead to neuroexcitability (seizures).

· Naloxone administration will increase neuroexcitibility.

· Use with caution in the elderly and patients with renal

   dysfunction.

· Not for use in chronic pain.  Do not exceed 600 mg / 24   hours.

 

                          Opioid Analgesics (continued)

 

Drug

Route

Dose (Adults > 50Kg)

Onset

Peak

Duration

Metabolism

Half Life

Comments

Methadone

(Dolophine®)

PO

 

2.5 mg 1 to 4 times daily

 

30 - 240 min

 

2 - 4 hr

 

4 - 24 hr

 

Liver

24 hr

· Used in chronic pain.

· Continued dosing can result in accumulation and respiratory

depression.

Morphine

 

 

 

 

(MS Contin®)

 

(Avinza®)

PO/SL

IM

IV

SQ

 

PO-SR

 

PO-SR

10 - 15 mg q 3 - 4 hr

4 - 10 mg q 3 - 4 hr

2 - 4 mg q 2 - 4 hr

4 -10 mg q 3 - 4 hr

 

MS Contin: 15 mg q 12 hr

 

Avinza:  30 mg daily

15 min

15 - 60 min

2 - 5 min

15 - 30 min

 

N/A

 

N/A

  - 2 hr

30 - 60 min

20 min

30 - 60 min

 

N/A

 

N/A

4 hr

4 hr

3 - 4 hr

4 - 7 hr

 

8 -12 hr

 

24 hr

Liver

1.5 - 2 hr

 

 

 

 

2 - 4 hr

 

15 hr

·Oral liquid concentrate is available.

·Active metabolite renally eliminated; use caution in elderly

and patients with renal insufficiency.

· Long-acting dosage forms should not be crushed.

·  Long-acting dosage forms should not be used to treat acute pain.

·  Avinza®  is not on the UIHC formulary, but is used by Medicaid.

Oxycodone

(Percocet®)**

 

(OxyContin®)

 

 

PO/SL

 

 

PO-SR

5 -10 mg q 4 - 6 hr-alone

or with acetaminophen

 

OxyContin: 10 mg q 12 hr

15 - 30 min

 

 

60 min

1 - 2 hr

 

 

2 - 3 hr

4 - 6 hr

 

 

12 hr

Liver

4 hr

· Available at UIHC as an immediate-release tablet  and oral

liquid concentration

·Percocet® contains oxycodone 5mg / acetaminophen 325mg

·Other strengths of Percocet®  are available outside UIHC.

· OxyContin® is a sustained-release tablet.  Do not crush.

· OxyContin® should not be used to treat acute pain.

*Analgesic duration of action does not correlate with half-life.

** Do not give more than 4 grams of acetaminophen per day (from all sources).

SR  - sustained release product

 

Guidelines for Patient-Controlled Intravenous Opioid Administration (PCA) for Adults with Acute Pain

 

The amount of opioid required to achieve comfort varies from patient to patient.  Adjust dosing to achieve patient comfort with minimal side effects. 

                     Drug§#

Usual Loading

Dose

Usual PCA Demand Bolus (Range)

Usual Lockout

Range

Usual

Basal Rate

Morphine (1 mg/ml)

5 – 10 mg

1 mg (0.5 - 2.5 mg)

5 - 10 min

None or 1 - 2 mg/hr

Hydromorphone (Dilaudid®) (0.2 mg/ml)

0.5 – 1.5 mg

0.2 mg (0.05 - 0.4 mg)

5 - 10 min

None or 0.1 - 0.4 mg/hr

Partially adapted from the Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, American Pain Society, 5th Ed. 2003.

§ Standard concentrations are listed in parentheses.

#Contact the Pain Service for other alternatives.

Also refer to UIHC Policy and Procedure for Patient Controlled Analgesia

Basal infusion rates are discouraged unless the patient has been taking scheduled opioids for more than one week. The addition of basal infusions to PCA increases the incidence and severity of opioid-induced adverse effects, including respiratory depression. 

 

 

Initial Fentanyl Transdermal Dosage (use only when converting another opioid TO fentanyl patch)*

 

 

Oral 24-hour morphine equivalent

(mg/day)

Fentanyl transdermal

(mcg/hr)

60 -134

25

135-224

50

225-314

75

315-404

100

405-494

125

495-584

150

585-674

175

675-764

200

765-854

225

855-944

250

945-1034

275

1035-1124

300

*Note: Do not use this table to convert from fentanyl transdermal system to other opioid analgesics because these conversion dosage recommendations are conservative.  Use of this table for conversion from fentanyl to other opioids can overestimate the dose of the new agent and may result in an overdosage.

 

Equianalgesic Chart 

 

Doses listed are equivalent to 10 mg of parenteral morphine. Doses should be titrated according to individual response. When converting to another opioid, the dose of the new agent should be reduced by 30-50% due to incomplete cross-tolerance between opioids.

 

Analgesic

Dosage

Parenteral

Oral

Fentanyl (SublimazeÒ)

0.1 - 0.2 mg

--------------

Hydrocodone

-------------

30 mg

Hydromorphone (DilaudidÒ)

1.5 mg

7.5 mg

Meperidine (DemerolÒ)

75 - 100 mg

300 mg §  (N)

Morphine

10 mg

30 mg §§

Oxycodone

-------------

20mg

§   Dosage in this range may lead to neuroexcitability.

§§ For a single dose, 10 mg IV morphine = 60